Search Within

Barbara Spitzer

Formats
  1. Journal Article (43)
  2. Meeting Abstract (31)
  3. Research Letter (3)
  4. Editorial (1)
Groups
  1. Pediatrics, Department of (78)
  2. Stem Cell Transplantation and Cellular Therapy Service (78)
  3. Department of Medicine (68)
  4. GSK Faculty (65)
  5. Center for Hematologic Malignancies (60)
  6. Tow Center for Developmental Oncology (TCDO) (57)

More Groups

People
  1. Richard O'Reilly (31)
  2. Nancy Kernan (29)
  3. Ross Levine (29)
  4. Andromachi Scaradavou (28)
  5. Kevin Curran (28)
  6. Farid Boulad (27)

More People

Years
  1. 2024 (8)
  2. 2023 (8)
  3. 2022 (8)
  4. 2021 (7)
  5. 2020 (12)
  6. 2019 (6)

More Years

Publications
  1. Blood (18)
  2. Biology of Blood and Marrow Transplantation (7)
  3. Blood Advances (7)
  4. Bone Marrow Transplantation (7)
  5. Pediatric Blood and Cancer (4)
  6. Cytotherapy (3)

More Publications

Publishers
  1. American Society of Hematology (25)
  2. Nature Publishing Group (16)
  3. Elsevier Inc. (9)
  4. American Association for Cancer Research (5)
  5. Wiley Periodicals, Inc (4)
  6. Elsevier Science Ltd. (3)

More Publishers

Results (78)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early CD4+ T-cell reconstitution is an excellent predictor for survival and non-relapse mortality in pediatric and young adult patients who develop moderate to severe acute graft-versus-host-disease; a dual center validation
    Meeting Abstract

    de Koning, C.; Prockop, S. E.; Van Roessel, I.; Klein, E.; Boulad, F.; Kernan, N. A.; Scaradavou, A.; Curran, K. J.; Spitzer, B.; Cancio, M.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin (ATG) exposure after ex vivo T-cell depleted hematopoietic cell transplantation is highly variable and impacts immune reconstitution in pediatric and young adult patients
    Meeting Abstract

    Lakkaraja, M.; Mauguen, A.; Boulad, F.; Spitzer, B.; Scaradavou, A.; Curran, K. J.; Cancio, M.; van Roessel, I.; Kernan, N. A.; O'Reilly, R. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Allogeneic CD34-selected HSCT following CAR T-cells is associated with low TRM and favorable OS in pediatric/young adult patients with relapsed/refractory B-ALL
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M. I.; Higman, M. A.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; Shah, N. C.; Spitzer, B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • De novo myelodysplastic syndromes in patients 20-50 years old characterized by frequent mutations in TP53 and transcription-related genes
    Meeting Abstract

    Epstein-Peterson, Z. D.; Spitzer, B.; McCarter, J.; McGovern, E.; Levine, R. L.; Tallman, M. S.
    Blood (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Identification of infants with non-SCID immune deficiency by newborn screening for SCID - The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Prockop, S.; Spitzer, B.; Walsh, M.; Ruggiero, J.; Kennedy, J.; Boulad, F.; Cancio, M.; Curran, K.; Kernan, N.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Early detection and molecular characterization of therapy-related leukemia in children reveals patterns of disease transformation and guides future surveillance protocols
    Meeting Abstract

    Spitzer, B.; Gundem, G.; Farnoud, N.; Millard, N.; McGovern, E.; Patel, M.; Levine, M.; Medina, J.; Zhou, Y.; Arango Ossa, J. E.; more...
    Blood (2018)

    Fulltext@MSK | Save